MedPath

上海华源长富药业集团旌德制药有限公司

Ownership
-
Established
2002-07-16
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

45

NMPA:45

Drug Approvals

Berberine Hydrochloride Tablets

Product Name
盐酸小檗碱片
Approval Number
国药准字H20068143
Approval Date
Jul 9, 2021
NMPA

Inosine Tabletes

Product Name
肌苷片
Approval Number
国药准字H20068141
Approval Date
Jul 9, 2021
NMPA

MENADIOL DIACETATE TABLETS

Product Name
醋酸甲萘氢醌片
Approval Number
国药准字H20068138
Approval Date
Jul 9, 2021
NMPA

Piracetam Tablets

Product Name
吡拉西坦片
Approval Number
国药准字H20068137
Approval Date
Jul 9, 2021
NMPA

Cefradine Capsules

Product Name
头孢拉定胶囊
Approval Number
国药准字H34022845
Approval Date
Jul 9, 2021
NMPA

Paracetamol Tablets

Product Name
对乙酰氨基酚片
Approval Number
国药准字H20068139
Approval Date
Jul 9, 2021
NMPA

Aspirin Enteric-coated Tablets

Product Name
阿司匹林肠溶片
Approval Number
国药准字H20068136
Approval Date
Jul 9, 2021
NMPA

Cefalexin Capsules

Product Name
头孢氨苄胶囊
Approval Number
国药准字H34022843
Approval Date
Jul 9, 2021
NMPA

Glibenclamide Tablets

Product Name
格列本脲片
Approval Number
国药准字H20068140
Approval Date
Jul 9, 2021
NMPA

Calcium Gluconate Tablets

Product Name
葡萄糖酸钙片
Approval Number
国药准字H20068145
Approval Date
Jul 9, 2021
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • Next

Clinical Trials

No trials found

News

No news found
© Copyright 2025. All Rights Reserved by MedPath